Results of Second Salvage Therapy for Acute Myeloid Leukemia in the Modern Era

Most published studies analyze the results of salvage therapies in primary refractory or first salvage (S1) AML patients only. Several novel agents and strategies are under evaluation for potential approval in the second-salvage (S2) setting.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Aron Simkins, Courtney D. DiNardo, Tapan Kadia, Naval Daver, Naveen Pemmaraju, Kiran Naqvi, Maro Ohanian, Koichi Takahashi, Yesid Alvarado, Mark Brandt, Sherry Pierce, Marina Konopleva, Elias Jabbour, Guillermo Garcia-Manero, Jorge Cortes, Farhad Ravandi- Source Type: research